Medscape covered research presented at the 2024 ATS International Conference by Michael Nicholson, DO, a second-year fellow in pulmonary and critical care at Temple University Hospital, that found bronchoscopic lung volume reduction (BLVR) significantly improved lung function in patients with alpha-1 antitrypsin deficiency (AATD), a subset of COPD patients who were previously excluded from landmark trials.